Blog
RSS FeedPosted by Michael Wonder on 25 May 2022
Target trial emulation for transparent and robust estimation of treatment effects for health technology assessment using real world data: opportunities and challenges
25 May 2022 - Evidence about the relative effects of new treatments is typically collected in randomised controlled trials. ...
Posted by Michael Wonder on 25 May 2022
New injectable immunotherapy treatment for rare form of triple negative breast cancer recommended by NICE
25 May 2022 - An estimated 100 people per year with triple negative breast cancer that has spread to other ...
Posted by Michael Wonder on 24 May 2022
Thousands of people in England could benefit after NICE recommends treatment option for two forms of sight loss
24 May 2022 - NICE recommends faricimab as treatment option for adults with wet age-related macular degeneration or diabetic macular oedema. ...
Posted by Michael Wonder on 24 May 2022
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
24 May 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
Posted by Michael Wonder on 23 May 2022
NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills
20 May 2022 - Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be ...
Posted by Michael Wonder on 20 May 2022
Lumasiran for treating primary hyperoxaluria type 1
20 May 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using lumasiran ...
Posted by Michael Wonder on 19 May 2022
Draft NICE guidance recommends innovative technology used to establish whether breast cancer has spread
17 May 2022 - A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the ...
Posted by Michael Wonder on 17 May 2022
Finerenone for treating chronic kidney disease in people with type 2 diabetes
17 May 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
Posted by Michael Wonder on 16 May 2022
More than 400 people could benefit from life-extending advanced lung cancer treatment after it was recommended for routine use on the NHS
16 May 2022 - Durvalumab recommended as an option for treating non-small-cell lung cancer. ...
Posted by Michael Wonder on 14 May 2022
Hundreds of patients to get life-extending lung cancer drug on the NHS
13 May 2022 - Hundreds of people with a form of the most common form of lung cancer could survive ...
Posted by Michael Wonder on 13 May 2022
NHS patients missing out on new medicines that could extend lives
13 May 2022 - Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are ...
Posted by Michael Wonder on 13 May 2022
Women with moderate to severe fibroids set to be offered new one a day treatment following final draft guidance from NICE
13 May 2022 - Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended ...
Posted by Michael Wonder on 11 May 2022
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy
11 May 2022 - NICE has published evidence based recommendations on the use of avelumab for adults with locally advanced ...
Posted by Michael Wonder on 09 May 2022
Choices that fail health and wellbeing
5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...
Posted by Michael Wonder on 08 May 2022
NHS rolls out life-saving arthritis drug to treat COVID
5 May 2022 - The NHS is rolling out a cutting-edge, life-saving COVID treatment from today, which is proven to ...